RxDoctor Payments Data

Raj Yalamanchilli, MD

Adult Reconstructive Orthopaedic Surgery · Bel Air, MDNPI 1316127319

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Microport Orthopedics Inc at 40.5% of the total. Reporting peaked in 2023 at $4,102 and has fallen 54.1% since, to $1,884 in 2025.

$14,147in general payments, 2019–2025

Across 124 payments — averaging $114.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$6K
  • Stryker$3K
  • Smith+Nephew$2K
  • Zimmer Biomet$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Boehringer Ingelheim$239
  • plus $878 from 18 others

What the payments were for

  • Travel & lodging$7,11650%
  • Food & beverage$6,85648%
  • Education$1751%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,147 in reported general payments places this provider in the 55th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$331,053
Medicare patients
534
Services billed
4,918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl119$1,035
Mupirocin96$658
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$524
Methylprednisolone54$338
Gabapentin59$227
Tramadol Hcl58$150
Cefadroxil14$63
Oxycodone Hcl12$58
Amoxicillin56$58
Hydromorphone Hcl11$48
Meloxicam11$31
Clindamycin Hcl12$19

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Bel Air

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →